Cardiovascular
and Renal Drugs Advisory Committee
CENTER FOR DRUG EVALUATION AND RESEARCH
Director, Division of Pathophysiology
Executive
Secretary
Advisors and
Consultants Staff HFD-21
Center for Drug
Evaluation and Research
Food and Drug
Administration
Rockville, Maryland 20857
301/827-7001 FAX 301/827-6776
Professor, Department of Medicine
251 Medical Science Bldg.
Associate Professor
of Medicine and Radiology
University of
420
Medical Director,
Cardiovascular Coordinating Center
Department of Cardiovascular Medicine/ F15
Professor of Medicine
Medical Service (111)
Professor of Medicine, Cardiovascular Division
Boston,
Massachusetts 02215
*Susanna L. Cunningham, Ph.D.
Expertise: Public Health, Nursing
Term: 10/24/01-06/30/05
Professor
Department of Biobehavioral Nursing
*Consumer Representative
Cardiovascular
and Renal Drugs Advisory Committee
CENTER FOR DRUG EVA
LUATION AND RESEARCH
Director, Integrative and Behavioral
Cardiology Program
Cardiovascular
Institute
Mount Sinai
Medical Center
William R.
Hiatt, M.D.
Term:
Expertise: Vascular Medicine
Professor of Medicine
Division of Geriatrics, Section of
Vascular Medicine
University of
P.O. Box B-179,
Expertise: Pediatric Nephrology
Term:
Professor of Pediatrics
Division of Pediatric Nephrology
University of Texas-Houston Medical School
MSB 3.124, 6431 Fannin Street
**John Neylan, M.D.
Term:
Expertise: Nephrology
Vice President
Clinical Research and
Development
Wyeth Research